Frontier IP Group PLC's (LON:FIPP) Neil Crabb talks to Proactive London's Katie Pilbeam about their recent announcements including on The Vaccine Group, one of the companies in its investment portfolio, which has appointed a chief executive officer - Dr Jeremy Salt.
As outlined in the Group’s interim results statement released on 24 March 2021, the Group enjoyed a strong first half to the financial year with the Group’s portfolio continuing to show strong commercial and technical progress.
And Crabb explains the Exscientia investment of up to $525m led by SoftBank.